Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from CORT

Top 3 Biotech Stocks to Anchor Your Portfolio

Amid robust global medicine spending, surging biopharma M&A activity, and technological advancements, the biotech industry is set for significant growth this year and beyond. Given the industry’s bright prospects, top biotech stocks Corcept Therapeutics (CORT), Entrada Therapeutics (TRDA), and Exelixis (EXEL) might be ideal buys now to anchor one’s portfolio.…

StockNews.com

5 Easy Changes That Make Your Living Room More Low Maintenance

If keeping up with a tidy, clean living room is keeping you up at night, make these simple switches that will make it easier to reset every day

Livingetc

“It isn’t just a modern headless instrument; it’s a resurrection of a pioneering legacy”: Cort reinvents its “revolutionary” headless Artisan bass design with the upgraded Space 5 model

New five-string model pairs own-brand headless tech with refined sculpting for a compact and tonally balanced build

Guitar World

From analysis to the latest developments in health,
read the most diverse news in one place.

Plunge into Profits With These 3 Biotech Stocks

The biotech industry's robust growth potential is driven by substantial pharma research and development, swift technological advancements, and lucrative government support. Given this backdrop, quality biotech stocks ProQR Therapeutics N.V. (PRQR), Regeneron Pharmaceuticals (REGN), and Corcept Therapeutics (CORT) could be solid buys now. Read on….

StockNews.com

“A powerful monster primed to nail the expectations of even the most demanding metal guitarist”: Cort unveils the KX707 EverTune 7-string – adding an ash top and some choice tweaks to its beloved KX700

The brand is continuing its tradition of offering well-spec'd builds at affordable price points with a stealthy 7-string that comes loaded with Seymour Duncan Sentient and Nazgûl pickups

Guitar World

Is Cort's new KX707 the best value 7-string guitar with an Evertune bridge that you can buy right now?

It's right up there in the extended-range stakes… but not much of a change from the previous model

MusicRadar

Elite 4 Biotech Stocks to Buy Now for Explosive Returns

With a wide range of applications across sectors, including health, agriculture, and industrial processing, rapid technological adoption, and government support, the biotech industry’s prospects appear promising. Thus, investors could consider buying biotech stocks Corcept Therapeutics (CORT), Jazz Pharmaceuticals (JAZZ), Incyte (INCY), and Exelixis (EXEL) for substantial gains. Read on….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

“This innovative instrument transcends boundaries, offering a sonic palette that's as diverse as your musical vision”: Cort and Hedras collaborate once again for the Triality X700 – an HSS twist on the pair’s progressive playing platform

Following the Duality and Mutility, this new offering looks to stretch beyond metal and rock realms and cater directly to the gigging guitarist demanding a do-it-all workhorse

Guitar World

3 Biotech Stocks to Buy for Investor Security

Despite macroeconomic challenges, the biotech industry thrives on innovation, demand, and technological breakthroughs. Therefore, fundamentally strong biotech stocks ANI Pharmaceuticals (ANIP), Vanda Pharmaceuticals (VNDA) and Corcept Therapeutics (CORT) might be ideal additions to your portfolio. Read on.

StockNews.com

3 A-Rated Biotech Stocks for Your 2024 Portfolio

Inelastic demand for healthcare products and services and the increasing government initiatives around the world are expected to boost the biotech industry. Therefore, it could be wise to buy fundamentally strong biotech stocks Entrada Therapeutics (TRDA), Corcept Therapeutics (CORT), and Alkermes (ALKS) this year. Read more.

StockNews.com

Investors Keeping a Close Eye on These 3 Biotech Stocks

Growing adoption of AI technologies by biopharmaceutical companies and growing foothold of personalized medicine are expected to drive growth in the biotech market. Therefore, it could be wise to buy fundamentally strong biotech stocks Regeneron Pharmaceuticals (REGN), Corcept Therapeutics (CORT), and Incyte (INCY). Read more.

StockNews.com

3 Biotechs with Massive Growth Potential

These three biotech stocks have massive growth opportunities on the horizon, and could add a huge boost to any portfolio. They play in some of the most in demand markets on the planet, and have track records of finding ways to introduce products into those markets to capture big profits.…

StockNews.com

Unlocking Biotech's Potential With 3 Stocks to Buy

The biotech industry’s growth is propelled by strong demand for medical support and interventions, favorable government initiatives, and rapid adoption of emerging technologies. Given the industry’s tailwinds, quality biotech stocks Shionogi (SGIOY), United Therapeutics (UTHR), and Corcept Therapeutics (CORT) could be ideal buys now. Read on….

StockNews.com

Which Stock Do Investors Consider a Heathier Investment: Bionano Genomics (BNGO) vs. Corcept Therapeutics (CORT)

The biotech industry is poised for long-term growth supported by government initiatives and the rising prevalence of chronic illnesses. While biotech stocks Bionano Genomics (BNGO) and Corcept Therapeutics (CORT) should benefit from the industry tailwinds, let us determine which stock could be considered a healthier investment.

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Time to Capitalize on These 3 Hot Biotech Stocks

The biotech industry is well-positioned for growth thanks to rising demand for quality healthcare, the prevalence of chronic diseases, and the government’s push to boost domestic biotech production and research. To that end, it could be wise to buy fundamentally strong biotech stocks Corcept Therapeutics (CORT), Ligand Pharmaceuticals (LGND), and…

StockNews.com

Are These 3 Biotech Stocks Good Buys?

Given that the biotech sector is rapidly expanding with robust demand, technology advancements, and government initiatives, fundamentally strong biotech stocks Incyte (INCY), Corcept Therapeutics (CORT), and Entrada Therapeutics (TRDA) look poised to generate significant returns. Hence, these stocks could be solid additions to your portfolio. Read on.

Guitar World

Cort G300 Glam and G300 Raw review

Cor-Tek might make a colossal number of guitars for other people, but its own brand, Cort, is gaining traction with sharply priced and very well-spec’d guitars such as this new G300 duo

StockNews.com

Top 3 Biotech Stocks with Breakout Potential

The biotech industry is well-positioned to witness significant growth due to technological advancements and government spending. Moreover, given the sector’s defensive nature, biotech stocks Amicus Therapeutics (FOLD), Corcept Therapeutics (CORT), and Harmony Biosciences (HRMY) might be solid buys in 2023. Read on.

Get all your
news in one place.

100’s of premium titles.
One news app.

Guitar World

Cort KX700 EverTune review

“Siri, show me a modern S-style that is spec’d up for metal and has state-of-the-art hardware that keeps it in tune all of the time…”

StockNews.com

2 Under-The-Radar Stocks to Buy Now Before Wall Street Catches On

With the combination of still-higher rates and widespread recessionary concerns, the stock market will likely stay under pressure for the near term. Therefore, it could be wise to buy fundamentally strong stocks Corcept Therapeutics (CORT) and Arcos Dorados (ARCO) that are flying under the radar now before Wall Street catches…

StockNews.com

2 Biotech Stocks Under $100 to Buy Now

The biotech industry flourished amid the pandemic, and lucrative federal investments are expected to drive further growth in the sector. Moreover, amid evolving variants of Coronavirus, the biotech industry is expected to remain in the limelight. Given the sound prospects of the industry, quality biotech stocks Gilead Sciences (GILD) and…

StockNews.com

3 Biotech Stocks to Accumulate During the Bear Market

2022 has been a challenging year for investors due to the combination of inflation and a slowing economy. Biotech stocks could be a place where investors can find outperformance given their low valuations and strong long-term fundamentals. Amgen (AMGN), Corcept Therapeutics (CORT), and Regneron (REGN) are 3 to consider.

Newsroom.co.nz

Growing institutional interest in community housing

Large investors see an opportunity in the $4 billion in housing supplements paid out annually, the government sees a win.

StockNews.com

3 Biotech Stocks to Beat the Bear Market

2022 is a challenging year for the market. After battling surging inflation for the first six months, another threat is emerging with rising recession risk. Biotech stocks could be a place where investors can find outperformance given their low valuations and strong long-term fundamentals.

StockNews.com

4 Biotech Stocks to Add to Your Watchlist

The surging demand for viable drugs and vaccines, advanced therapies, and increasing investments in research and development make the biotech industry’s prospects bright. Thus, it could be wise to invest in fundamentally sound biotech stocks Amgen (AMGN), Vertex Pharmaceuticals (VRTX), BioNTech (BNTX), and Corcept Therapeutics (CORT).

1 2 3

People

Kritika SarmahHer

727 stories

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the European Commission

Vertex Pharmaceuticals Incorporated

65 stories

BNTX

64 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.